1Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherethrombotic events in patients with acute myocardial infarction.Circulation,2004,109:3171-3175
2Gurbel PA,Becker RC,Mann KG,et al.Platelet function monitoring in patients with coronary artery disease.J Am Coll Cardiol,2007,50:1822-1834
3Barragan P,Bouvier JL,Roquebert PO,et al.Resistance to thienopyridines:Clinical detection of coronary stent thrombosisby monitoring of vasodilator-stimulated phosphoprotein phosphorylation.Catheter Cardiovasc Interv,2003,59:295-302
4Leon MB,Bairn DS,Popma JJ,et al.A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting.Stent Anticoagulation Restenosis Study Investigators.N Engl J Med,1998,339:1665-1671
5Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCICURE study.Lancet,2001,358:527-533
6Steinhubl SR,Bergor PB,Mann Ⅲ JT,et al.Clopidogrel for the reduction of events during observation.early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial(CREDO).JAMA,2002,288:2411-2420
7Bhatt DL,Fox KA,Hacke W,et al.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.N Engl J Med,2006,354:1706-17017
8Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence.predictors.and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293(17):2126-2130
9Mollmann H,Nef HM,Harem CW,et al.How to manage patients with need for antiplatelet therapy in the setting of(un-)planned surgery.Clin Res Cardiol,2009,98(1):8-15
